Table 2 Analysis for tumor response at 3 months after patients receiving TACE-A.

From: The efficacy of drug-eluting bead or conventional transarterial chemoembolization plus apatinib for hepatocellular carcinoma with portal vein tumor thrombus

Tumor response

Before matching

After matching

C-TACE-A

D-TACE-A

P value

C-TACE-A

D-TACE-A

P value

Partial response

41

14

–

23

13

–

Stable disease

16

13

–

6

12

–

Progressive disease

20

26

–

15

20

–

Objective response rate

53.2%

26.4%

0.002

48.9%

31.1%

0.021

Disease control rate

74%

50%

0.007

64.4%

57.8%

0.317

Back to article page